Navigation Links
Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
Date:9/25/2008

addition, Quark's current clinical pipeline includes AKIi-5, developed by Quark for the prevention of acute kidney injury (AKI) following major cardiac surgery, currently in Phase I/IIa clinical trials via systemic delivery and DGFi with open IND for prevention of delayed graft function in kidney transplantation. Based on publicly available information, Quark believes AKIi-5 was the first siRNA delivered systemically in a human clinical trial.

In addition, Quark has a broad pipeline of siRNA drug candidates based on novel structures developed internally. The Company expects to utilize the structures to develop additional RNAi drug candidates.

Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel. Additional information is available at http://www.quarkpharma.com
Quark Pharmaceuticals, Inc. The Ruth Group (investors / media)

Juliana Friedman Sara Ephraim / Janine McCargo

+972 89 30 5111 (646) 536-7004 / 7033

jfriedman@quarkpharma.com sephraim@theruthgroup.com

jmccargo@theruthgroup.com


'/>"/>
SOURCE Quark Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015  Olympus, a precision technology leader in designing ... among other core businesses, announced today the opening of ... Park, MN. The new medical device research ... the company for continued long-term growth in the surgical ... place on April 27 and was attended by ...
(Date:4/28/2015)... 28, 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... Shareholders and Associates, I am very excited to ... much-awaited Phase IIb clinical trial for oral insulin (ORMD-0801) and ... commence the trial in the coming weeks. This clinical trial will ... marks a significant milestone for the company, literally putting us ...
(Date:4/28/2015)... Minn. , April 28, 2015 ANI ... the Company plans to release its first quarter 2015 ... opening of the U.S. financial markets. The earnings press ... of the Company,s website, www.anipharmaceuticals.com . ... Executive Officer, and Charlotte C. Arnold , Vice ...
Breaking Medicine Technology:Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 2Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 4Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update Letter 2Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update Letter 3ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results 2
(Date:4/28/2015)... April 28, 2015 Helping Families and ... when a loved one dies can be overwhelming. For ... funeral arrangements and final tribute can be downright ... need, Beinhauer Family Funeral Homes knows this ... to families by doubling its number of certified celebrants. ...
(Date:4/28/2015)... San Diego, CA (PRWEB) April 28, 2015 ... over 1000 members sign up for their newly launched ... lost over 10,000 pounds and counting in just two ... provides a tailored diet and exercise plan for men ... follow and achieve their weight loss and weight maintenance ...
(Date:4/28/2015)... CENTENNIAL, Colo. (PRWEB) April 28, 2015 A ... among brain, heart or lung damage, 66 percent of Americans ... coincide with National Stroke Awareness Month in May, shed light ... people can take to help prevent a stroke. By ... prevented. , A stroke is a “ brain attack ...
(Date:4/28/2015)... Hellen Chen, who is a bestselling author and marriage ... a study conducted by Washington University, between 1991 ... increased by 20% while the number of unfaithful husbands has ... released this year from the Journal of Marital ... both spouses admit to infidelity, either physical or emotional is ...
(Date:4/28/2015)... It’s not all about the law at the ... civil litigation and plaintiff’s personal injury lawyer that has also ... it’s also about giving back to the community. This ... Cancer Research Center Innovator’s Network. , “I believe there is ... lawyers can and do good community-focused work in their communities,” ...
Breaking Medicine News(10 mins):Health News:Beinhauer's Increasing Number of Celebrants to Meet Growing Demand for Personalized Funeral Ceremonies 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 3Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 3Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 2Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 3Health News:Seattle Attorney Paul Schneiderman Helping to Combat Cancer 2
... Testing,Markets, WASHINGTON, Jan. 24 The Department ... Plc to divest assets,relating to three clinical testing ... million acquisition of Harcourt Assessment. The,Department said that ... higher prices to purchasers of clinical tests, including ...
... stops inflammation-induced colon cancer in its tracks , ... at increased risk of developing colon cancer. New data ... Japan, identified a central role for the soluble factor ... in which inflammation of the bowel was induced by ...
... immune system attacks , , THURSDAY, Jan. 24 (HealthDay ... protects itself from the immune system,s biochemical assault. , ... anthrax virulence, they also suggest a new target, known ... the pathogen, said study leader Evgeny Nudler, a professor ...
... consumers on the use of Zetia and ... ... Shapiro filed,a proposed class-action lawsuit against Merck (NYSE: MRK ) and,Schering-Plough ... violated state consumer protection laws arising,from the sale and marketing of Zetia ...
... New pharmacy accreditation standards for Specialty Pharmacy, ... Jan. 24 URAC called for public,comment ... The programs,are Specialty Pharmacy, Mail Service Pharmacy ... and Property and Casualty. The,new programs closely ...
... adult children of parents with BRCA mutations would be more ... (HealthDay News) -- Even though most U.S. medical groups are ... that predispose them to developing breast and/or ovarian cancer later ... of the Fox Chase Cancer Center in Philadelphia, and her ...
Cached Medicine News:Health News:Justice Department Requires Divestitures in Pearson's Acquisition of Harcourt Assessment 2Health News:Justice Department Requires Divestitures in Pearson's Acquisition of Harcourt Assessment 3Health News:JCI table of contents: Jan. 24, 2008 2Health News:JCI table of contents: Jan. 24, 2008 3Health News:JCI table of contents: Jan. 24, 2008 4Health News:JCI table of contents: Jan. 24, 2008 5Health News:JCI table of contents: Jan. 24, 2008 6Health News:JCI table of contents: Jan. 24, 2008 7Health News:Key Anthrax Virulence Factor Discovered 2Health News:Key Anthrax Virulence Factor Discovered 3Health News:CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough 2Health News:CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough 3Health News:URAC Seeks Public Comment on Standards for New Pharmacy Accreditation Programs 2Health News:URAC Seeks Public Comment on Standards for New Pharmacy Accreditation Programs 3Health News:URAC Seeks Public Comment on Standards for New Pharmacy Accreditation Programs 4Health News:Next Generation of Parents More Likely to Back Genetic Testing 2
Raney clip applying forceps, length 6 1/4"....
... instrumentation, capable of comminution, aspiration ... means of ultra-sonic energy. Allows ... and, in particular, parenchymatous organs, ... tissue-selection and non-traumatic preparation with ...
... has everything you expect from the ... the advantage of integrated circuitry and ... , Unlike other surgical techniques, ultrasonic ... fibrous tissues such as nerves and ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 7.5 mm....
Medicine Products: